Vimian Group AB

Price Chart

Risk-Adjusted Performance

Also Listed On

Vimian Group AB (VIMIAN) Price Performance

Vimian Group AB (VIMIAN) trades on Nasdaq Stockholm in SEK. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at SEK25.52, down 2.82% from the previous close.

Over the past year, VIMIAN has traded between a low of SEK24.92 and a high of SEK46.00. The stock has lost 36.9% over this period. It is currently 44.5% below its 52-week high.

Vimian Group AB has a market capitalization of $14.07B, with a price-to-earnings ratio of 41.08.

About Vimian Group AB

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, and education and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and orthopedic implants for veterinarians and universities under the Movora brand name. Vimian Group AB (publ) was incorporated in 2020 and is headquartered in Stockholm, Sweden.